Inventor
WOOLFORD ALISON JO-ANNE
GB29 patents
⚠️ This page may combine multiple inventors who share the name “WOOLFORD ALISON JO-ANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
11 patentsUS7385059B2Jun 10, 2008
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD33 citations95
US7977477B2Jul 12, 2011
Benzimidazole derivatives and their use as protein kinase inhibitors
ASTEX THERAPEUTICS LTD35 citations92
US7700625B2Apr 20, 2010
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
ASTEX THERAPEUTICS LTD25 citations92
US9458158B2Oct 4, 2016
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD11 citations84
US9676768B2Jun 13, 2017
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD8 citations83
US7745638B2Jun 29, 2010
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD8 citations83
US7825140B2Nov 2, 2010
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD7 citations73
US11866428B2Jan 9, 2024
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD2 citations72
US9428439B2Aug 30, 2016
Hydrobenzamide derivatives as inhibitors of Hsp90
ASTEX THERAPEUTICS LTD2 citations62
US9914719B2Mar 13, 2018
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
ASTEX THERAPEUTICS LTD0 citations51
US9051278B2Jun 9, 2015
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD0 citations51
GLAXOSMITHKLINE IP DEV LTD
6 patentsUS10485806B2Nov 26, 2019
Nrf2 regulators
GLAXOSMITHKLINE IP DEV LTD3 citations72
US10272095B2Apr 30, 2019
NRF2 regulators
GLAXOSMITHKLINE IP DEV LTD4 citations72
US10604509B2Mar 31, 2020
Nrf2 regulators
GLAXOSMITHKLINE IP DEV LTD2 citations71
US10144731B2Dec 4, 2018
Nrf2 regulators
GLAXOSMITHKLINE IP DEV LTD2 citations71
US10364256B2Jul 30, 2019
Biaryl pyrazoles as NRF2 regulators
GLAXOSMITHKLINE IP DEV LTD2 citations59
US10351530B2Jul 16, 2019
Arylcyclohexyl pyrazoles as NRF2 regulators
GLAXOSMITHKLINE IP DEV LTD0 citations40
CHESSARI GIANNI
3 patentsUS8101648B2Jan 24, 2012
Hydroxybenzamide derivatives and their use as inhibitors of HSP90
CHESSARI GIANNI20 citations91
US8530469B2Sep 10, 2013
Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90
CHESSARI GIANNI11 citations82
US8816087B2Aug 26, 2014
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
CHESSARI GIANNI2 citations61
OTSUKA PHARMA CO LTD
3 patentsUS10457669B2Oct 29, 2019
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD5 citations82
US11001575B1May 11, 2021
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD4 citations71
US11939321B2Mar 26, 2024
Benzolactam compounds as protein kinase inhibitors
OTSUKA PHARMA CO LTD0 citations61
BERDINI VALERIO
2 patentsUS8080666B2Dec 20, 2011
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
BERDINI VALERIO6 citations73
US8779147B2Jul 15, 2014
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
BERDINI VALERIO2 citations62